Cargando…
Differences between hospitals in attainment of parathyroid hormone treatment targets in chronic kidney disease do not reflect differences in quality of care
BACKGROUND: Transparency in quality of care (QoC) is stimulated and hospitals are compared and judged on the basis of indicators of performance on specific treatment targets. In patients with chronic kidney disease, QoC differed significantly between hospitals. In this analysis we explored additiona...
Autores principales: | Peeters, Mieke J, van Zuilen, Arjan D, AJG van den Brand, Jan, Blankestijn, Peter J, AGJ ten Dam, Marc, FM Wetzels, Jack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467173/ https://www.ncbi.nlm.nih.gov/pubmed/22867424 http://dx.doi.org/10.1186/1471-2369-13-82 |
Ejemplares similares
-
Abdominal aortic calcification in patients with CKD
por: Peeters, Mieke J., et al.
Publicado: (2016) -
Multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners. Design of The MASTERPLAN Study [ISRCTN73187232]
por: van Zuilen, Arjan D, et al.
Publicado: (2006) -
A retrospective study of focal segmental glomerulosclerosis: clinical criteria can identify patients at high risk for recurrent disease after first renal transplantation
por: Maas, Rutger JH, et al.
Publicado: (2013) -
Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: An analysis of the MASTERPLAN cohort
por: Vervloet, Marc G, et al.
Publicado: (2012) -
Uremic Solutes in Chronic Kidney Disease and Their Role in Progression
por: van den Brand, Jan A. J. G., et al.
Publicado: (2016)